Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
World Journal of Surgical Oncology|July 12, 2017
Variation of sentinel lymphatic channels (SLCs) and sentinel lymph nodes (SLNs) assessed by contrast-enhanced ultrasound (CEUS) in breast cancer patientsYing Wang, Wenbin Zhou, Cuiying Li, et al.
Nanomedicine (London, England)|April 8, 2022
Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancerWeiwei Zhang, Yinggang Xu, Xiaoqing Shi, et al.
Frontiers in Oncology|December 26, 2022
RecurIndex assay as an aid for adjuvant chemotherapy decisions in HR-positive HER2-negative breast cancer patientsHaibo Wang, Li Ma, Yanan Zhang, et al.
BMJ Open|March 31, 2025
Omission of axillary lymph node dissection in patients with breast cancer with axillary pathological complete response confirmed by stained region lymph node biopsy after neoadjuvant systemic therapy (SrLNB study): study protocol for a single-arm, single-centre, phase-II trialLingjun Ma, Rui Chen, Mingyu Wang, et al.
British Journal of Clinical Pharmacology|August 24, 2022
A prospective, randomized clinical trial of emergency treatment of chemotherapy-induced neutropenia and febrile neutropenia by pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF)Xiaofeng Huang, Shuo Li, Wenjie Shi, et al.
Nanomedicine (London, England)|January 27, 2021
Retrospective comparisons of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for breast cancerYan Li, Xiang Chen, Qiannan Zhu, et al.
BMC Cancer|November 12, 2024
Exploring optimal administration timing of pegylated recombinant human granulocyte colony-stimulating factor for chemotherapy-induced neutropenia in early breast cancer treated with pharmorubicin and endoxan: a prospective randomized controlled clinical trialYinggang Xu, Lifeng Huang, Jue Wang, et al.
Frontiers in Oncology|February 23, 2023
Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete responseYinggang Xu, Weiwei Zhang, Siqi Wang, et al.
Plos One|April 25, 2013
Low serum creatine kinase levels in breast cancer patients: a case-control studyHong Pan, Kai Xia, Wenbin Zhou, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|March 8, 2023
Nanoparticle albumin-bound paclitaxel-based neoadjuvant regimen: A promising treatment option for HER2-low-positive breast cancerWenjie Shi, Xinyu Wan, Ye Wang, et al.
Pageof 11